Illumina Grows Clinical IVD Portfolio with Introduction of NextSeq™ 550Dx System

November 17, 2017 Leave a comment 5,110 Views

Illumina announced the introduction of its NextSeq™ 550Dx instrument, the company’s second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system. With the NextSeq 550Dx and also the MiSeqDx, Illumina now has a highly robust diagnostic NGS product portfolio capable of ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: NextSeq 550Dx

Illumina Grows Clinical IVD Portfolio with Introduction of NextSeq™ 550Dx System

Circall – fast and accurate methodology for discovery of circular RNAs from paired-end RNA-sequencing data

Single-cell analysis support the use of PDAC organoids as a clinically relevant model for in vitro studies of tumor heterogeneity

lncRNA Regulation of IFNɣ and Its Effect on Checkpoint Inhibitor Expression Enhances Understanding of Therapeutic Cancer Target

Detection of atherosclerosis by small RNA-sequencing analysis of extracellular vesicle enriched serum samples

Mayo Clinic collaborates with Personalis to to offer clinical-grade comprehensive cancer genomic sequencing

Isoform variability is an important source of latent information in RNA-seq data that can be used to improve clinical prediction models.

Transcriptome-wide RNA-protein interaction predictions